United Health Products, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 05, 2021 at 03:45 pm IST
Share
United Health Products, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported net loss was USD 0.724416 million compared to USD 9.22 million a year ago.
For the nine months, sales was USD 0.000059 million compared to USD 0.000563 million a year ago. Net loss was USD 29.08 million compared to USD 10.54 million a year ago. Basic loss per share from continuing operations was USD 0.13 compared to USD 0.06 a year ago.
United Health Products, Inc. develops, manufactures, and markets a hemostatic gauze for the healthcare and wound care sectors. Its gauze product, HemoStyp, is derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. HemoStyp hemostatic gauze is a flexible, silk-like material that is applied by placing the gauze onto the bleeding tissue. The supple material can be easily folded and manipulated as needed to fit the size of the wound or incision. In surface bleeding and surgical situations, the product quickly converts to a translucent gel that allows the physician or surgeon to monitor the coagulation process. In superficial bleeding situations, HemoStyp can be bonded to an adhesive plastic bandage or integrated into a traditional gauze component to address a range of needs, including traumatic bleeding injuries and prolonged bleeding following hemodialysis. Its customer base includes hospitals, surgery centers, clinics and others.
UNITED HEALTH PRODUCTS, INC. 
